Imperial College London

ProfessorEricAlton

Faculty of MedicineNational Heart & Lung Institute

Chair in Gene Therapy
 
 
 
//

Contact

 

+44 (0)20 7594 7929e.alton

 
 
//

Assistant

 

Miss Samia Soussi +44 (0)20 7594 7980

 
//

Location

 

Emmanuel Kaye BuildingRoyal Brompton Campus

//

Summary

 

Publications

Citation

BibTex format

@inproceedings{Pabary:2015:10.1136/thoraxjnl-2015-207770.61,
author = {Pabary, R and Alegro, A and Alton, EWFW and BIlton, D and Morales, S and Smrekar, F and Davies, JC},
doi = {10.1136/thoraxjnl-2015-207770.61},
pages = {A34--A34},
publisher = {BMJ PUBLISHING GROUP},
title = {TOWARDS THE CLINICAL APPLICATION OF ANTI-PSEUDOMONAL BACTERIOPHAGE: ACTIVITY IS RETAINED FOLLOWING NEBULISATION WITH A RANGE OF COMMERCIALLY AVAILABLE NEBULISER SYSTEMS},
url = {http://dx.doi.org/10.1136/thoraxjnl-2015-207770.61},
year = {2015}
}

RIS format (EndNote, RefMan)

TY  - CPAPER
AU - Pabary,R
AU - Alegro,A
AU - Alton,EWFW
AU - BIlton,D
AU - Morales,S
AU - Smrekar,F
AU - Davies,JC
DO - 10.1136/thoraxjnl-2015-207770.61
EP - 34
PB - BMJ PUBLISHING GROUP
PY - 2015///
SN - 0040-6376
SP - 34
TI - TOWARDS THE CLINICAL APPLICATION OF ANTI-PSEUDOMONAL BACTERIOPHAGE: ACTIVITY IS RETAINED FOLLOWING NEBULISATION WITH A RANGE OF COMMERCIALLY AVAILABLE NEBULISER SYSTEMS
UR - http://dx.doi.org/10.1136/thoraxjnl-2015-207770.61
UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000365353600062&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=a2bf6146997ec60c407a63945d4e92bb
ER -